Skip to Content

MD Anderson Events

Hematology Grand Rounds - Department of Lymphoma/Myeloma

Hematology Grand Rounds - Department of Lymphoma/Myeloma

 

Hematology Grand Rounds
 
Department of Lymphoma/Myeloma
In Collaboration with the
Department of Leukemia and Department of Stem Cell Transplantation
 
 
Michael Weber, PhD
University of Virginia School of Medicine
 
 
Presenting
 
“Adaptive cell signaling: A mechanism of
resistance and guide to combination therapies”
 
Wednesday, March 26, 2014
8:00 a.m. – 9:00 a.m.
Pickens Tower, 3rd Floor, Rooms 1, 2, 7 & 8
 
After attending this activity, the target audience of Physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:
 
  • Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge);
  • Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
  • Update knowledge and collaboration in trials and research (knowledge, competence, performance);
  • Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);
 
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of The University of Texas MD Anderson Cancer Center that the program chair(s), planning committee member, faculty/teacher/ author, or CME activity reviewer must disclose any relevant financial relationships with commercial interests whose products may be discussed in the activities, if any.  MD Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.               
                                                                                                                                                                                                                                                                               

Date: 3/26/14, 8am to 9am
Time: 3/26/14, 8am to 9am
Location: Pickens Academic Tower, Floor 3, Room 7 (FCT3.4165)
Format: All Employee Meeting
CME: 1.0
Facilitator: Laura Lam, PhD
Speaker: Michael Weber, M.D.
Contact: Curtisha Jones - cljones1@mdanderson.org